Albrecht K, Pablo P, Eidner T, Hoese G, Wassenberg S, Zink A, Callhoff J.
Arthritis Care Res (Hoboken). 2025 Feb;77(2):169-177. doi: 10.1002/acr.24799. Epub 2022 Oct 11. PMID: 34590439; PMCID: PMC11771685.
Association Between Rheumatoid Arthritis Disease Activity and Periodontitis Defined by Tooth Loss: Longitudinal and Cross-Sectional Data From Two Observational Studies. Rios Rodriguez V, Torgutalp M, Proft F, Rademacher J, Protopopov M, Spiller L, Haibel H, Sieper S, Poddubnyy D.
Rheumatology (Oxford). 2025 Mar 1;64(3):1162-1169. doi: 10.1093/rheumatology/keae133. PMID: 38507706.
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy. Naddei R, Ridella F, Bovis F, Trincianti C, Avrusin I, Januskeviciute G, Burrone M, Rebollo-Giménez A, Minden K, Ekelund M, Barone P, Rumba-Rozenfelde I, Shafaie N, Swart JF, Ruperto N, Ravelli A, Consolaro A.
Rheumatology (Oxford). 2025 Apr 1;64(4):2143-2152. doi: 10.1093/rheumatology/keae326. PMID: 38964350.
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score. Poddubnyy D, Garrido-Cumbrera M, Sommerfleck F, Navarro-Compán V, Bundy C, Makri S, Correa-Fernández J, Akerkar S, Davies J, Karam E.
Rheumatology (Oxford). 2025 Apr 1;64(4):1873-1879. doi: 10.1093/rheumatology/keae521. PMID: 39321311; PMCID: PMC11962975.
Diagnostic delay in patients from the international map of axial spondyloarthritis: geographic, socio-demographic and disease-related factors. Horn V, Cancino Matamala , Steinheuer LM, Obermayer B, Fritz K, Nguyen AL, Juhran KS, Plattner C, Bösel D, Oldenburg L, Urbicht M, Schulz AR, Saliutina M, Mantzivi E, Lissner D, Conrad T, Mashreghi MF, Zundler S, Sonnenberg E, Schumann M, Haag LM, Beule D, Flatz L, Trjanoski Z, D'Haens G, Weidinger C, Mei HE, Siegmund B, Thurley K, Hegazy AN.
Gastroenterology. 2025 Feb;168(2):327-343. doi: 10.1053/j.gastro.2024.09.021. Epub 2024 Sep 28. PMID: 39343250.
Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4(+) T cells as predictors for response to integrin a4ß7-blocking therapy in inflammatory bowel disease. Studenic P, Meißner Y, Kearsley-Fleet L, De CD, Cock CD.
Best Pract Res Clin Rheumatol. 2025 Mar;39(1):102017. doi: 10.1016/j.berh.2024.102017. Epub 2024 Oct 15. PMID: 39406599.
Role of rheumatoid arthritis registries worldwide: What have they taught us? Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, Fonseca T, Fragoulis GE, Galetti I, Gerosa M, Hernández-Rodríguez J, Lanzillotta M, Marinello D, Martin T, Martinez-Valle F, Maslinska M, Moretti M, Mosca M, Müller-Ladner U, Müller-Ladner U, Nalli C, Orsolini G, Pamfil C, Perez-Garcia G, Priori R, Quattrocchio G, Ramming A, Regola F, Romão VC, Silva , Laar JV, Vicente-Edo MJ, Vinker S, Alexander T.
Lancet Rheumatol. 2025 Jan;7(1):e64-e71. doi: 10.1016/S2665-9913(24)00192-9. Epub 2024 Oct 29. PMID: 39486422.
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework. Werth VP, Merrill JT, Furie RA, Dörner T, van VR, Lipsky PE, Weiswasser M, Korish S, Schafer PH, Stern M, Martinelli S, Li SC, Schärli S, Ridha Ali SL, Giampaoli S, Galli SJ, Delev N.
J Am Acad Dermatol. 2025 Mar;92(3):435-443. doi: 10.1016/j.jaad.2024.09.074. Epub 2024 Oct 25. PMID: 39461504.
Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial. Chiarolla CM, Schulz AR, Meir M, Schmidt S, Xiao Y, Reu-Hofer S, Romero-Olmedo AJ, Falcone V, Hoffmann K, Büttner-Herold M, Prelog M, Rosenwald A, Hengel H, Lohoff M, Chang HD, Schlegel N, Mei HE, Berberich-Siebelt F.
Mucosal Immunol. 2025 Feb;18(1):162-175. doi: 10.1016/j.mucimm.2024.11.001. Epub 2024 Nov 7. PMID: 39521274.
Pro-inflammatory NK-like T cells are expanded in the blood and inflamed intestine in Crohn's disease.